Related Experiment Video
Updated: Jul 17, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Population-based epidemiology of rotavirus hospitalisations in Switzerland
Barbara Bucher1, Christoph Aebi
1Department of Paediatrics, University of Bern, Bern, Switzerland.
Insights
Rotavirus (RV) hospitalizations in young children are less common in Switzerland than in Europe. Factors like urban living and non-Swiss origin influence admission rates, not just dehydration severity.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Rotaviruses (RV) are a leading cause of severe gastroenteritis in children under 5.
- New RV vaccines offer protection, necessitating current disease burden data for effective implementation.
- Understanding RV epidemiology is crucial for public health strategies and vaccine policy.
Purpose of the Study:
- To determine the population-based incidence of rotavirus hospitalizations in children under 5 in Switzerland.
- To identify demographic and geographic factors associated with rotavirus hospitalization.
- To inform strategies for rotavirus vaccine usage.
Main Methods:
- Retrospective analysis of rotavirus hospitalizations.
- Study period: 1999-2003.
- Involved urban and rural populations representing 12% of the Swiss population.
Main Results:
- Rotavirus accounted for 38% of pediatric gastroenteritis hospitalizations.
- Overall incidence was 1.5/1000 child-years, peaking at 2.6/1000 in 13-24 month olds.
- Higher incidence in urban (1.71) vs. remote mountain areas (0.71) and in non-Swiss children (3.0 vs. 1.1).
Conclusions:
- Swiss rotavirus hospitalization rates are low compared to other European countries.
- Urban residence and non-Swiss origin are associated with higher hospitalization rates.
- Factors beyond dehydration severity influence hospital admission decisions for rotavirus.
Background:
Rotaviruses (RV) are the most common cause of dehydrating gastroenteritis requiring hospitalisation in children <5 years of age. A new generation of safe and effective RV vaccines is available. Accurate data describing the current burden of RV disease in the community are needed to devise appropriate strategies for vaccine usage.
Methods:
Retrospective, population-based analysis of RV hospitalisations in children <5 years of age during a 5-year period (1999-2003) in a both urban and rural area inhabited by 12% of the Swiss population.
Results:
Of 406 evaluable cases, 328 were community-acquired RV infections in children <5 years of age. RV accounted for 38% of all hospitalisations for gastroenteritis. The overall hospitalisation incidence in the <5-year-old was 1.5/1000 child-years (peak incidence, 2.6/1000 child-years in children aged 13-24 months). The incidence of community-acquired RV hospitalisations was significantly greater in children of non-Swiss origin (3.0 vs. 1.1/1000 child-years, relative risk 2.7; 95% CI 2.2-3.4), who were younger, but tended to be less severely dehydrated on admission than Swiss children. In comparison with children from urban areas, RV hospitalisation incidence was significantly lower among those residing in the remote mountain area (0.71 vs. 1.71/1000 child years, relative risk 2.2, 95% CI 1.6-3.1).
Conclusion:
Population-based RV hospitalisation incidence was low in comparison with other European countries. Significantly greater hospitalisation rates among children living in urban areas and those from non-Swiss families indicate that factors other than the severity of RV-induced dehydration are important driving forces of hospital admission.
Related Concept Videos
Poliomyelitis
Investigation of Disease Outbreaks
Respiratory Syncytial Virus Disease
Cholera
Vaccinations
Influenza
